(-)-epigallocatechin 3-gallate multiple interactions ISO AHCY (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of AHCY mRNA CTD PMID:22079256 (-)-epigallocatechin 3-gallate decreases expression ISO AHCY (Homo sapiens) 6480464 epigallocatechin gallate results in decreased expression of AHCY protein CTD PMID:31195006 (1->4)-beta-D-glucan multiple interactions ISO Ahcy (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AHCY mRNA CTD PMID:36331819 1,2-dimethylhydrazine decreases expression ISO Ahcy (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of AHCY mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO Ahcy (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of AHCY mRNA CTD PMID:22206623 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of AHCY mRNA CTD PMID:32145629 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Ahcy (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Ahcy (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrabromodibenzodioxine increases expression ISO Ahcy (Mus musculus) 6480464 2 more ... CTD PMID:27604104 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of AHCY mRNA CTD PMID:18465118 and PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of AHCY mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ahcy (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of AHCY mRNA CTD PMID:21570461 and PMID:26377647 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:19954255 2-hydroxypropanoic acid decreases expression ISO AHCY (Homo sapiens) 6480464 Lactic Acid results in decreased expression of AHCY mRNA CTD PMID:30851411 2-palmitoylglycerol increases expression ISO AHCY (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of AHCY mRNA CTD PMID:37199045 3,4-methylenedioxymethamphetamine increases expression ISO Ahcy (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of AHCY mRNA CTD PMID:20188158 4,4'-diaminodiphenylmethane decreases expression ISO Ahcy (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of AHCY mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol decreases expression ISO Ahcy (Mus musculus) 6480464 bisphenol S results in decreased expression of AHCY mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases expression ISO AHCY (Homo sapiens) 6480464 bisphenol S results in increased expression of AHCY protein CTD PMID:34186270 4-hydroxyphenyl retinamide increases expression ISO Ahcy (Mus musculus) 6480464 Fenretinide results in increased expression of AHCY mRNA CTD PMID:28973697 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of AHCY mRNA CTD PMID:31881176 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of AHCY mRNA CTD PMID:28959563 aflatoxin B1 increases methylation ISO AHCY (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of AHCY gene CTD PMID:27153756 aflatoxin B1 increases mutagenesis EXP 6480464 Aflatoxin B1 results in increased mutagenesis of AHCY gene CTD PMID:36908029 all-trans-retinoic acid decreases expression ISO AHCY (Homo sapiens) 6480464 Tretinoin results in decreased expression of AHCY mRNA CTD PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of AHCY mRNA CTD PMID:16483693 aristolochic acid A increases expression ISO AHCY (Homo sapiens) 6480464 aristolochic acid I results in increased expression of AHCY protein CTD PMID:33212167 arsane multiple interactions ISO AHCY (Homo sapiens) 6480464 [Arsenic results in increased expression of and results in increased activity of AHCY protein] which results in increased chemical synthesis of Homocysteine and Arsenic results in increased expression of and results in increased activity of AHCY protein CTD PMID:18487201 arsane increases expression ISO AHCY (Homo sapiens) 6480464 Arsenic results in increased expression of AHCY mRNA CTD PMID:18487201 arsenic atom increases expression ISO AHCY (Homo sapiens) 6480464 Arsenic results in increased expression of AHCY mRNA CTD PMID:18487201 arsenic atom multiple interactions ISO AHCY (Homo sapiens) 6480464 [Arsenic results in increased expression of and results in increased activity of AHCY protein] which results in increased chemical synthesis of Homocysteine and Arsenic results in increased expression of and results in increased activity of AHCY protein CTD PMID:18487201 arsenite(3-) multiple interactions ISO AHCY (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to AHCY mRNA] and arsenite promotes the reaction [G3BP1 protein binds to AHCY protein] CTD PMID:32406909 arsenous acid increases expression ISO AHCY (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of AHCY mRNA CTD PMID:22521957 azoxystrobin increases expression ISO AHCY (Homo sapiens) 6480464 azoxystrobin results in increased expression of AHCY mRNA CTD PMID:33512557 benzene increases expression ISO Ahcy (Mus musculus) 6480464 Benzene results in increased expression of AHCY mRNA CTD PMID:15120971 and PMID:15122651 benzo[a]pyrene increases methylation ISO AHCY (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of AHCY promoter CTD PMID:27901495 benzo[b]fluoranthene decreases expression ISO Ahcy (Mus musculus) 6480464 benzo(b)fluoranthene results in decreased expression of AHCY mRNA CTD PMID:26377693 benzoates decreases expression ISO AHCY (Homo sapiens) 6480464 Benzoates analog results in decreased expression of AHCY mRNA CTD PMID:29472718 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of AHCY mRNA CTD PMID:25181051 and PMID:30903817 bisphenol A decreases expression ISO AHCY (Homo sapiens) 6480464 bisphenol A results in decreased expression of AHCY protein CTD PMID:34186270 bisphenol A decreases expression ISO Ahcy (Mus musculus) 6480464 bisphenol A results in decreased expression of AHCY mRNA and bisphenol A results in decreased expression of AHCY protein CTD PMID:30951980 and PMID:35999755 bisphenol A affects expression ISO AHCY (Homo sapiens) 6480464 bisphenol A affects the expression of AHCY mRNA CTD PMID:30903817 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of AHCY mRNA and bisphenol A results in decreased expression of AHCY protein CTD PMID:22649256 and PMID:32145629 bisphenol F decreases expression ISO Ahcy (Mus musculus) 6480464 bisphenol F results in decreased expression of AHCY mRNA CTD PMID:30951980 buspirone increases expression EXP 6480464 Buspirone results in increased expression of AHCY mRNA CTD PMID:24136188 buta-1,3-diene decreases expression ISO Ahcy (Mus musculus) 6480464 1 and 3-butadiene results in decreased expression of AHCY mRNA CTD PMID:29038090 cadmium atom multiple interactions ISO AHCY (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AHCY protein CTD PMID:33040242 cadmium dichloride multiple interactions ISO AHCY (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AHCY protein CTD PMID:33040242 cadmium dichloride increases expression ISO AHCY (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of AHCY protein CTD PMID:24527689 caffeine decreases expression ISO AHCY (Homo sapiens) 6480464 Caffeine results in decreased expression of AHCY protein CTD PMID:31195006 carbon nanotube increases expression ISO Ahcy (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 ceruletide decreases expression EXP 6480464 Ceruletide results in decreased expression of AHCY protein CTD PMID:18024178 chloropicrin decreases expression ISO AHCY (Homo sapiens) 6480464 chloropicrin results in decreased expression of AHCY mRNA CTD PMID:26352163 and PMID:28476498 chlorpyrifos decreases expression ISO Ahcy (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of AHCY mRNA CTD PMID:37019170 choline multiple interactions ISO Ahcy (Mus musculus) 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in decreased expression of AHCY mRNA more ... CTD PMID:20938992 more ... choline multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of AHCY protein CTD PMID:19566968 cisplatin increases expression ISO AHCY (Homo sapiens) 6480464 Cisplatin results in increased expression of AHCY mRNA and Cisplatin results in increased expression of AHCY protein CTD PMID:21424131 and PMID:27392435 cisplatin multiple interactions ISO AHCY (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of AHCY mRNA CTD PMID:27392435 clofibrate decreases expression ISO Ahcy (Mus musculus) 6480464 Clofibrate results in decreased expression of AHCY mRNA CTD PMID:17585979 copper atom decreases expression EXP 6480464 Copper results in decreased expression of AHCY mRNA CTD PMID:22465980 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of AHCY mRNA CTD PMID:22465980 CU-O LINKAGE decreases expression ISO AHCY (Homo sapiens) 6480464 cupric oxide results in decreased expression of AHCY protein CTD PMID:25470785 D-penicillamine multiple interactions ISO Ahcy (Mus musculus) 6480464 Penicillamine promotes the reaction [ATP7B protein mutant form results in decreased expression of AHCY protein] CTD PMID:22945834 D-penicillamine increases activity ISO Ahcy (Mus musculus) 6480464 Penicillamine results in increased activity of AHCY protein CTD PMID:22945834 diarsenic trioxide increases expression ISO AHCY (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of AHCY mRNA CTD PMID:22521957 doxorubicin decreases expression ISO AHCY (Homo sapiens) 6480464 Doxorubicin results in decreased expression of AHCY mRNA CTD PMID:18510171 doxorubicin increases expression ISO AHCY (Homo sapiens) 6480464 Doxorubicin results in increased expression of AHCY mRNA CTD PMID:29803840 enzyme inhibitor multiple interactions ISO AHCY (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of AHCY protein CTD PMID:23301498 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of AHCY mRNA CTD PMID:18035473 folic acid multiple interactions ISO Ahcy (Mus musculus) 6480464 [1 more ... CTD PMID:20938992 more ... folic acid multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of AHCY protein CTD PMID:19566968 folic acid decreases expression ISO Ahcy (Mus musculus) 6480464 Folic Acid deficiency results in decreased expression of AHCY mRNA and Folic Acid deficiency results in decreased expression of AHCY protein CTD PMID:25384423 folic acid increases expression ISO Ahcy (Mus musculus) 6480464 Folic Acid results in increased expression of AHCY mRNA and Folic Acid results in increased expression of AHCY protein CTD PMID:30920123 formaldehyde decreases expression ISO AHCY (Homo sapiens) 6480464 Formaldehyde results in decreased expression of AHCY mRNA CTD PMID:23649840 fumonisin B1 decreases expression ISO Ahcy (Mus musculus) 6480464 fumonisin B1 results in decreased expression of AHCY mRNA CTD PMID:16221962 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of AHCY mRNA CTD PMID:24136188 glycine betaine decreases expression ISO Ahcy (Mus musculus) 6480464 Betaine results in decreased expression of AHCY mRNA CTD PMID:22945834 glycine betaine decreases expression EXP 6480464 Betaine results in decreased expression of AHCY mRNA CTD PMID:26391144 homocysteine multiple interactions ISO AHCY (Homo sapiens) 6480464 [Arsenic results in increased expression of and results in increased activity of AHCY protein] which results in increased chemical synthesis of Homocysteine CTD PMID:18487201 isoprenaline increases expression ISO Ahcy (Mus musculus) 6480464 Isoproterenol results in increased expression of AHCY mRNA CTD PMID:20003209 ivermectin decreases expression ISO AHCY (Homo sapiens) 6480464 Ivermectin results in decreased expression of AHCY protein CTD PMID:32959892 L-methionine multiple interactions ISO Ahcy (Mus musculus) 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in decreased expression of AHCY mRNA more ... CTD PMID:20938992 and PMID:29127188 L-methionine multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of AHCY protein CTD PMID:19566968 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of AHCY mRNA CTD PMID:24136188 lipopolysaccharide multiple interactions ISO AHCY (Homo sapiens) 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of AHCY mRNA CTD PMID:35877022 lovastatin decreases expression ISO Ahcy (Mus musculus) 6480464 Lovastatin results in decreased expression of AHCY mRNA CTD PMID:20493250 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of AHCY protein CTD PMID:30467583 methidathion increases expression ISO Ahcy (Mus musculus) 6480464 methidathion results in increased expression of AHCY mRNA CTD PMID:34813904 methotrexate affects expression ISO Ahcy (Mus musculus) 6480464 Methotrexate affects the expression of AHCY mRNA CTD PMID:18502557 methylmercury chloride decreases expression ISO AHCY (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of AHCY mRNA CTD PMID:23179753 and PMID:27188386 mono(2-ethylhexyl) phthalate decreases expression ISO Ahcy (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of AHCY mRNA CTD PMID:22401849 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of AHCY mRNA CTD PMID:20360939 N-nitrosodiethylamine multiple interactions ISO Ahcy (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of AHCY mRNA CTD PMID:29127188 N-nitrosomorpholine decreases expression EXP 6480464 N-nitrosomorpholine results in decreased expression of AHCY protein CTD PMID:19716841 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of AHCY mRNA CTD PMID:33484710 Nonylphenol decreases expression EXP 6480464 nonylphenol results in decreased expression of AHCY protein CTD PMID:19260726 ozone multiple interactions ISO Ahcy (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of AHCY mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of AHCY mRNA CTD PMID:34911549 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of AHCY mRNA and Acetaminophen affects the expression of AHCY protein CTD PMID:16687475 and PMID:19103213 paracetamol increases expression ISO AHCY (Homo sapiens) 6480464 Acetaminophen results in increased expression of AHCY mRNA CTD PMID:22230336 parathion increases expression ISO Ahcy (Mus musculus) 6480464 Parathion results in increased expression of AHCY mRNA CTD PMID:34813904 PCB138 multiple interactions ISO Ahcy (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:21673325 perfluorododecanoic acid decreases expression EXP 6480464 perfluorododecanoic acid results in decreased expression of AHCY protein CTD PMID:26168851 perfluorooctane-1-sulfonic acid multiple interactions ISO Ahcy (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AHCY mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression ISO Ahcy (Mus musculus) 6480464 perfluorooctanoic acid results in increased expression of AHCY protein CTD PMID:37422089 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of AHCY mRNA CTD PMID:19162173 picoxystrobin increases expression ISO AHCY (Homo sapiens) 6480464 picoxystrobin results in increased expression of AHCY mRNA CTD PMID:33512557 pirinixic acid increases expression ISO Ahcy (Mus musculus) 6480464 pirinixic acid results in increased expression of AHCY protein CTD PMID:15226431 pirinixic acid decreases expression ISO Ahcy (Mus musculus) 6480464 pirinixic acid results in decreased expression of AHCY mRNA CTD PMID:16221962 and PMID:23811191 pirinixic acid multiple interactions ISO Ahcy (Mus musculus) 6480464 PPARA protein affects the reaction [pirinixic acid results in decreased expression of AHCY mRNA] CTD PMID:16221962 potassium chromate increases expression ISO AHCY (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of AHCY mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO AHCY (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of AHCY mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile increases expression ISO Ahcy (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of AHCY mRNA CTD PMID:28903501 propiconazole increases metabolic processing ISO Ahcy (Mus musculus) 6480464 propiconazole results in increased metabolism of AHCY protein CTD PMID:19714882 Propiverine affects binding EXP 6480464 propiverine binds to AHCY protein CTD PMID:29273565 pyrimidifen increases expression ISO AHCY (Homo sapiens) 6480464 pyrimidifen results in increased expression of AHCY mRNA CTD PMID:33512557 rac-lactic acid decreases expression ISO AHCY (Homo sapiens) 6480464 Lactic Acid results in decreased expression of AHCY mRNA CTD PMID:30851411 resveratrol affects expression ISO AHCY (Homo sapiens) 6480464 resveratrol affects the expression of AHCY protein CTD PMID:22234583 rotenone increases expression ISO AHCY (Homo sapiens) 6480464 Rotenone results in increased expression of AHCY mRNA CTD PMID:33512557 S-adenosyl-L-homocysteine increases hydrolysis ISO AHCY (Homo sapiens) 6480464 AHCY results in increased hydrolysis of S-Adenosylhomocysteine CTD PMID:26974671 sarin decreases expression ISO AHCY (Homo sapiens) 6480464 Sarin results in decreased expression of AHCY mRNA CTD PMID:19522546 SB 431542 multiple interactions ISO AHCY (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of AHCY protein CTD PMID:37664457 sodium arsenite affects methylation ISO AHCY (Homo sapiens) 6480464 sodium arsenite affects the methylation of AHCY gene CTD PMID:28589171 sodium arsenite increases expression ISO AHCY (Homo sapiens) 6480464 sodium arsenite results in increased expression of AHCY protein CTD PMID:29207610 streptozocin multiple interactions ISO Ahcy (Mus musculus) 6480464 [Streptozocin co-treated with Dietary Fats] results in decreased expression of AHCY mRNA and [Streptozocin co-treated with Dietary Fats] results in increased methylation of AHCY gene CTD PMID:29127188 T-2 toxin increases expression ISO AHCY (Homo sapiens) 6480464 T-2 Toxin results in increased expression of AHCY protein CTD PMID:34581912 tetrachloromethane multiple interactions ISO Ahcy (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of AHCY mRNA CTD PMID:29127188 tetrahydrocurcumin affects expression ISO Ahcy (Mus musculus) 41410880 Tetrahydrocurcumin affects expression of protein and mRNA in ischemia/reperfusion CBS+/- mice RGD thimerosal decreases expression ISO AHCY (Homo sapiens) 6480464 Thimerosal results in decreased expression of AHCY mRNA CTD PMID:27188386 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of AHCY mRNA CTD PMID:34492290 titanium dioxide increases expression ISO Ahcy (Mus musculus) 6480464 titanium dioxide results in increased expression of AHCY mRNA CTD PMID:29264374 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of AHCY mRNA CTD PMID:19448997 trimellitic anhydride increases expression ISO Ahcy (Mus musculus) 6480464 trimellitic anhydride results in increased expression of AHCY mRNA CTD PMID:19042947 Triptolide decreases expression ISO Ahcy (Mus musculus) 6480464 triptolide results in decreased expression of AHCY mRNA CTD PMID:32835833 tungsten increases expression ISO Ahcy (Mus musculus) 6480464 Tungsten results in increased expression of AHCY mRNA CTD PMID:30912803 valproic acid affects expression ISO Ahcy (Mus musculus) 6480464 Valproic Acid affects the expression of AHCY mRNA CTD PMID:17292431 valproic acid decreases expression ISO AHCY (Homo sapiens) 6480464 Valproic Acid results in decreased expression of AHCY mRNA CTD PMID:23179753 and PMID:27188386 vancomycin increases expression ISO Ahcy (Mus musculus) 6480464 Vancomycin results in increased expression of AHCY mRNA CTD PMID:18930951 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of AHCY gene CTD PMID:31079544 warfarin decreases expression ISO Ahcy (Mus musculus) 6480464 Warfarin results in decreased expression of AHCY mRNA CTD PMID:20493250